Unfolding the role of protein misfolding in neurodegenerative diseases
The DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neurodegenerative diseases, such as AD and DLB, are often characterized as diseases of protein aggregation (30–33).”
From APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia (2021) · cites this paper as [30]
In the citing paper
“Importantly, most of these age-related primary neurodegenerative diseases involve disorders of protein processing and aggregation.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
In the citing paper
“The hallmark feature of these proteinopathies are the fibrillary aggregates of misfolded or hyperphosphorylated proteins (59).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundMACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
Background
Cited by
Items 901–1,000 of 1,001
Ramakrishnan, P., Joshi, A., Fazil, M., & Yadav, P. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122334 · Cited by 13
Ze Systems Generate Entropy to Forge Truth
Tqemaladze, J. (2026) · Longevity Horizon · doi:10.65649/vgrw2c93 · Cited by 12
Effects of lysine residues on structural characteristics and stability of tau proteins
Lee, M., Baek, I., Choi, H., Kim, J. I., & Na, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.056 · Cited by 12
Yau, J., & Sharpe, S. J. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.08.002 · Cited by 12
Growth-Regulated Hsp70 Phosphorylation Regulates Stress Responses and Prion Maintenance
Kao, C.-H., Ryu, S. W., Kim, M. J., Wen, X., Wimalarathne, O., & Paull, T. T. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00628-19 · Cited by 13
“Disruption of these networks can cause a number of human disorders, including Alzheimer's, Parkinson's, and prion-related diseases (Soto, 2003).”
BackgroundInstantaneous fibrillation of egg white proteome with ionic liquid and macromolecular crowding
Bharmoria, P., Mondal, D., Pereira, M. M., Neves, M. C., Almeida, M. R., Gomes, M. C., Mano, J. F., Bdikin, I. K., Ferreira, R. A. S., Coutinho, J. A. P., et al. (2020) · Communications Materials · doi:10.1038/s43246-020-0035-0 · Cited by 13
Ghosh, R., Raveendranath, R., & Kishore, N. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.11.210 · Cited by 13
Single molecule imaging of protein aggregation in Dementia: Methods, insights and prospects
Danial, J. S. H., & Klenerman, D. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105327 · Cited by 12
“The aggregation of misfolded proteins plays a critical role in most neurodegenerative diseases (Goedert and Spillantini, 2006; Koffie et al., 2009; Goedert, 2015; Chiti and Dobson, 2006; Dobson, 2003; Benilova et al., 2012; Cleary et al., 2005; Haass and Selkoe, 2007; Knowles et al., 2014; Soto, 2003).”
Ettcheto, M., Sánchez‐López, E., Cano, A. C., Carrasco, M., Herrera, K., Manzine, P. R., Espinosa-Jiménez, T., Busquets, O., Verdaguer, E., Olloquequi, J., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00646-w · Cited by 12
Nanomaterials for neurodegenerative diseases: Molecular mechanisms guided design and applications
Li, T., Hou, X., Yu, Q., Duan, X., Yan, P., Zhu, H., Xie, Z., & Zhang, H. (2021) · Nano Research · doi:10.1007/s12274-021-3865-2 · Cited by 12
Influence of sleep disruption on protein accumulation in neurodegenerative diseases
Wang, X., Wang, R., & Li, J. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2021.10 · Cited by 17
Saha, J., Bose, P., Dhakal, S., Ghosh, P., & Rangachari, V. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00495 · Cited by 12
TRP and Rhodopsin Transport Depends on Dual XPORT ER Chaperones Encoded by an Operon
Chen, Z., Chen, H.-C., & Montell, C. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.018 · Cited by 12
“…a wide range of neurodegenerative diseases, ranging from Alzheimer’s disease to Huntington’s disease, Parkinson’s disease, and certain forms of autosomal dominant retinal degeneration resulting from accumulation of misfolded rhodopsin, which is the classical GPCR (Dryja et al., 1990; Soto, 2003).”
BackgroundBRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells
Campo, M. D., Oliveira, C. R., Scheper, W., Zwart, R., Korth, C., Müller‐Schiffmann, A., Kostallas, G., Biverstål, H., Presto, J., Johansson, J., et al. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1769-y · Cited by 12
“Protein conformation-dependent neurotoxicity is a common key molecular pathway involved in different neurodegenerative diseases including AD [47, 48].”
BackgroundRoy, A., Tiwari, S., Karmakar, S., Reddy, K. A., & Pandey, L. M. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.120 · Cited by 12
Lee, W., Al‐Ramahi, I., Jeong, H.-H., Jang, Y., Lin, T., Adamski, C. J., Lavery, L. A., Rath, S., Richman, R., Bondar, V. V., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci156616 · Cited by 13
“1172/JCI156616 potential positive regulators of ATXN1 (Supplemental Table 6); (2) knockdown of TG5 remarkably suppressed the ATXN1[82Q]induced fly eye degeneration (Figure 3A) and significantly improved motor deficits in fruit flies that express human ATXN1[82Q] in the CNS (31), as evident by the increase in their cli…”
BackgroundMouse Senile Amyloid Fibrils Deposited in Skeletal Muscle Exhibit Amyloidosis-Enhancing Activity
Qian, J., Yan, J., Ge, F., Zhang, B., Fu, X., Tomozawa, H., Sawashita, J., Mori, M., & Higuchi, K. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000914 · Cited by 13
“native monomeric protein [19,20].”
März, P., Kunz, D., Bimmler, D., Berkemeier, C. M., Özbek, S., Dimitriades‐Schmutz, B., Haybaeck, J., Otten, U., & Graf, R. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9715-0 · Cited by 12
“Generation of cleaved, misfolded peptides which aggregate and accumulate often leads to neuronal dysfunction (Selkoe 2003; Soto 2003).”
Role of Oxidative Stress, ER Stress and Ubiquitin Proteasome System in Neurodegeneration
Kumar, P. (2014) · MOJ Cell Science & Report · doi:10.15406/mojcsr.2014.01.00010 · Cited by 15
“The activity of the ubiquitin proteasome system (UPS) is significantly misregulated in these stress conditions and leads to protein aggregates and other toxic product accumulation thus leading to brain damaging conditions [37,38].”
BackgroundTurner, B. J., Lopes, E. C., & Cheema, S. S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10782 · Cited by 13
“Key words: aggregation; amyotrophic lateral sclerosis; DDC; fibroblasts; oxidant stress; proteasome; SOD1 Abnormal protein misfolding, oligomerisation and deposition is associated with selective neuronal death in late-onset neurodegenerative disease [Taylor et al., 2002; Soto, 2003, reviews].”
BackgroundReversion of protein aggregation mediated by Sso7d in cell extracts of Sulfolobus solfataricus
Guagliardi, A., MANCUSI, L., & Rossi, M. (2004) · Biochemical Journal · doi:10.1042/bj20040131 · Cited by 12
Sun, H., Li, M., Li, Y., Na, Z., Li, J., Li, X., Liu, Y., Ji, Q., Zhou, L., Su, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147709 · Cited by 11
“UPS dysfunction can be directly induced by mHtt [9,10], which disrupts vesicular transport, blocks autophagosome–lysosome fusion, downregulates neuronal autophagy levels, and finally leads to neuronal death [11].”
BackgroundPérez‐Berlanga, M., Laferrière, F., & Polymenidou, M. (2019) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3424 · Cited by 11
Huo, G., Chen, W., Wang, J., Chu, X., Xu, W., Li, B., Zhang, Y., Xu, B., & Zhou, X. (2020) · RSC Advances · doi:10.1039/c9ra09943c · Cited by 12
Genç, B., Gözütok, Ö., Koçak, N., & Özdinler, P. H. (2020) · Cells · doi:10.3390/cells9020502 · Cited by 12
“Misfolded proteins are a hallmark of neurodegenerative diseases [8,9] including ALS [10,11].”
BackgroundPalomino‐Hernández, O., Buratti, F. A., Sacco, P. S., Rossetti, G., Carloni, P., & Fernández, C. O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145061 · Cited by 12
“Neurodegenerative disorders such as Parkinson’s and Alzheimer’s are among the human diseases associated with the self-assembly of polypeptides into amyloid structures [1,2].”
BackgroundTheory of polymers in poor solvents: Inter-chain interaction, second virial coefficient, and Θ point
Liu, L., Duan, C., & Wang, R. (2022) · Polymer · doi:10.1016/j.polymer.2022.125312 · Cited by 11
Barletti, B., Lucchesi, G., Muscat, S., Errico, S., Barbut, D., Danani, A., ZASLOFF, M. A., Grasso, G., Chiti, F., & Caminati, G. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.113115 · Cited by 11
Mandal, S., Jana, D., Dolai, J., Sarkar, A. K., Ghorai, B. K., & Jana, N. R. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00771 · Cited by 13
Bai, X., Liu, C., Li, H.-J., Zhang, Z., Cui, W.-B., An, F., Zhang, Z., Wang, D., & Fei, D. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106714 · Cited by 12
Curcumin Reduces Amyloid Beta Oligomer Interactions with Anionic Membranes
Sallaberry, C. A., Voss, B. J., Stone, W. B., Estrada, F., Bhatia, A., Soto, J. D., Griffin, C. W., & Zanden, C. M. V. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00512 · Cited by 12
Endoplasmic Reticulum Stress, PrP Trafficking, and Neurodegeneration
Soto, C. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.09.001 · Cited by 11
“The initial model, that PrPSc aggregates cause direct neurotoxicity, seemed reasonable considering that other, more prevalent neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases are also characterized by cerebral accumulation of misfolded protein aggregates (Soto, 2003).”
BackgroundSelf-citationDubnikov, T., & Cohen, E. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00048 · Cited by 15
“Late onset (Amaducci and Tesco, 1994) and the deposition of aggregated proteins in the brain are common features of these illnesses (Soto, 2003).”
BackgroundTransmission of pathogenic protein aggregates in Alzheimer’s disease
Schwarzman, A. L., & Sarantseva, S. V. (2017) · Molecular Biology · doi:10.1134/s0026893317030141 · Cited by 11
“Numerous studies have shown that the pathogenesis of a significant number of neurodegenerative diseases, including Parkinson’s disease, Huntington’s disease, and prion diseases, involves the aggregation of cell proteins [8].”
Zhang, G., Lin, L., Qi, D., & Zhang, H. (2017) · Autophagy · doi:10.1080/15548627.2017.1339843 · Cited by 11
Young, L. E. A., Shoben, C., Ricci, K., & Williams, D. C. (2018) · Journal of Neurogenetics · doi:10.1080/01677063.2018.1531857 · Cited by 12
“Accumulation of misfolded proteins is associated with many neurodegenerative diseases and can induce the ER unfolded protein response and result in aberrant Ca2þ release from the ER (Hetz & Mollereau, 2014; Soto, 2003).”
BackgroundÖzcelik, D., & Pezacki, J. P. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00301 · Cited by 12
Fluorescence spectroscopic analysis of heavy metal induced protein denaturation
Senthil, S. K., Murugan, P. K., Selvam, S., Chandhana, J. P., Babu, T. G. S., & Kandasamy, E. (2020) · Materials Today Proceedings · doi:10.1016/j.matpr.2020.04.693 · Cited by 11
Menezes, R., Foito, A., Jardim, C., Costa, I., Garcia, G., Rosado-Ramos, R., Freitag, S., Alexander, C. J., Outeiro, T. F., Stewart, D., et al. (2020) · Antioxidants · doi:10.3390/antiox9090789 · Cited by 14
“Besides sharing oxidative stress and chronic inflammation as common pathological processes, neurodegenerative diseases (NDs) are also known as conformational disorders, as they are associated with protein misfolding and aggregation [3,4] in a process thought to lead to neuronal death.”
BackgroundAnalysis of Toxic Amyloid Fibril Interactions at Natively Derived Membranes by Ellipsometry
Smith, R., Nabok, A., Blakeman, B., Xue, W.-F., Abell, B., & Smith, D. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132309 · Cited by 12
Shinkai‐Ouchi, F., Yamakawa, Y., Hara, H., Tobiume, M., Nishijima, M., Hanada, K., & Hagiwara, K. (2010) · Proteome Science · doi:10.1186/1477-5956-8-53 · Cited by 11
“Nevertheless, the observation that prnp mice are viable [7] indicates the functional redundancy of PrP, and raises the question of whether a ‘loss-of-function’ of PrP is responsible for the neuronal cell death [8].”
BackgroundCalnexin inhibits thermal aggregation and neurotoxicity of prion protein
Wang, W., Chen, R., Kan, L., Wu, D., Huang, L., Huang, T., & Xiao, G. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22698 · Cited by 11
“…that PrP could be deglycosylated when it was retrograde transported to cytoplasm, and accumulation of unglycosylated species were more likely to be converted into a PrPSc-like form [Lehmann and Harris, 1997; Suzuki et al., 2000] which induced caspase-3-mediated cell death [Hetz and Soto, 2003].”
BackgroundPatel, K. A., Sethi, R., Dhara, A. R., & Roy, I. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.05.014 · Cited by 12
McCue, H. V., Chen, X., Barclay, J. W., Morgan, A., & Burgoyne, R. D. (2015) · Scientific Reports · doi:10.1038/srep14392 · Cited by 12
Kim, T.-H., Son, W. S., Morshed, M. N., Londhe, A. M., Jung, S. Y., Park, J., Park, W., Lim, S. M., Park, K. D., Cho, S. J., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.033 · Cited by 12
Wu, C. F., & Shea, J. (2012) · Biological and medical physics series · doi:10.1007/978-1-4614-2146-7_9 · Cited by 11
Salciccia, C., Costanzo, M., Ruocco, G., Porreca, F., Vivacqua, G., Fabbrini, G., Belvisi, D., Ladogana, A., & Poleggi, A. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105997 · Cited by 12
Wen, Y., Zhu, H., Song, F., Chen, R., Zheng, C., Pi, M., Zhang, Y., & Wang, Y. (2025) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2025.126621 · Cited by 12
Protein Misfolding Cyclic Amplification
Moda, F., Pritzkow, S., & Soto, C. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5305-5_6 · Cited by 10
Self-citationNguyen, P. T., Sharma, R. B., Rej, R. N., Carufel, C. A. D., Roy, R., & Bourgault, S. (2016) · RSC Advances · doi:10.1039/c6ra15373a · Cited by 10
Hong, S., Go, Y. K., Derrick, J. S., Han, S., Kim, J., Lim, M. H., & Kim, S. H. (2018) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.8b01824 · Cited by 10
Wang, Y., Meng, F., Lu, T., Wang, C., & Li, F. (2021) · RSC Advances · doi:10.1039/d1ra00354b · Cited by 11
Zhao, L., Wang, S., Hu, Q., Jia, H., Xin, Y., Luo, L., & Meng, F. (2022) · Nanoscale · doi:10.1039/d1nr08090c · Cited by 10
Interactions of Curcumin’s Degradation Products with the Aβ 42 Dimer: A Computational Study
Dehabadi, M. H., Caflisch, A., Ilie, I. M., & Firouzi, R. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c05846 · Cited by 10
Jalili, S., Panji, M., Mahdavimehr, M., Ahangar, A. M., Shirzad, H., Nezhad, S. A. M., & Palhano, F. L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130003 · Cited by 10
RetractedPrP-containing aggresomes are cytosolic components of an ER quality control mechanism
Dubnikov, T., Ben‐Gedalya, T., Reiner, R., Hoepfner, D., Cabral, W. A., Marini, J. C., & Cohen, E. (2016) · Journal of Cell Science · doi:10.1242/jcs.186981 · Cited by 11
“Accordingly, the deposition of insoluble protein aggregates in designated cellular or extracellular sites is a hallmark of various neurodegenerative illnesses (Soto, 2003).”
BackgroundPorojan, C., Mitrovic, S. M., Yeo, D. C. J., & Furey, A. (2016) · Food Additives & Contaminants Part A · doi:10.1080/19440049.2016.1217070 · Cited by 10
“, in the brain) could clump or cluster together with the potential of forming the types of plaques that are characteristic of diseases like ALS and AD (Soto 2003; Haass & Selkoe 2007; Dunlop & Rodgers 2011; Rodgers & Dunlop 2011).”
BackgroundPRAS40 alleviates neurotoxic prion peptide‐induced apoptosis via mTOR‐AKT signaling
Yang, W., Yang, L., Song, Z., Shah, S. Z. A., Cui, Y., Li, C., Zhao, H., Gao, H., Zhou, X., & Zhao, D. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12685 · Cited by 10
Lu, T., Meng, F., Wei, Y., Li, Y., Wang, C., & Li, F. (2018) · Physical Chemistry Chemical Physics · doi:10.1039/c7cp06468c · Cited by 11
Peripheral Delivery of Neural Precursor Cells Ameliorates Parkinson’s Disease-Associated Pathology
Edwards, G. A., Gamez, N., Armijo, E., Kramm, C., Morales, R., Taylor-Presse, K., Schulz, P. E., Soto, C. A., & Moreno‐González, I. (2019) · Cells · doi:10.3390/cells8111359 · Cited by 11
“The pathophysiology underlying PD includes the aggregation of misfolded alpha-synuclein protein that generates intracellular Lewy bodies [2,6,7].”
BackgroundSelf-citationChakraborty, D., Chebaro, Y., & Wales, D. J. (2019) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp04778f · Cited by 11
Chetty, R., Pandya, S. R., & Singh, M. (2019) · New Journal of Chemistry · doi:10.1039/c9nj04155a · Cited by 10
Niu, B., Mackness, B. C., Zitzewitz, J. A., Matthews, C. R., & Gross, M. L. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00425 · Cited by 10
Han, A. R., Jeon, E. H., Kim, K. W., Lee, S. K., Ohn, C.-Y., Park, S. J., Kang, N. S., Koo, T., Hong, K. B., & Choi, S. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116550 · Cited by 10
Oleanen Induces Apoptosis of Cervical Cancer Cells by Up-Regulation of Bim
Gan, N., Chen, G., Zhang, W., & Zhou, J. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31822b62be · Cited by 10
“In contrast, the exogenous pathway mainly acts through Fas/FasR and TNFR to trigger the activation of caspase 8, and the activation of the endoplasmic reticulum pathway is a consequence of cell stress that is caused by protein misfolding.(15,16) To identify the pathway responsible for the oleanen-induced apoptosis in…”
BackgroundPrediction of Protein Structure by Simulating Coarse-grained Folding Pathways: A Preliminary Report
Colubri, A. (2004) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2004.10506953 · Cited by 10
Protein Misfolding Cyclic Amplification of Infectious Prions
Moda, F. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.06.016 · Cited by 12
Sin, O., Mata‐Cabana, A., Seinstra, R. I., & Nollen, E. A. A. (2018) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3042 · Cited by 10
“…trap assay, Filter retardation assay, Dot blot, C. elegans [Background] One pathological feature of neurodegenerative diseases like Parkinson’s, Alzheimer’s and polyglutamine diseases is the presence of protein aggregates in distinct areas of the brain (reviewed in Soto, 2003; Stroo et al., 2017).”
MethodHeat Shock Proteins and Neurodegenerative Diseases
Brown, I. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-39717-7_18 · Cited by 12
Raina, N., Singh, E., Ahanger, I. A., Shahid, M., Israil, Hassan, M. I., Ahmad, F., Singh, A. K., & Islam, A. (2023) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2023.121909 · Cited by 9
A comprehensive application of FiveFold for conformation ensemble-based protein structure prediction
Niazi, S. K., & Yang, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-17022-0 · Cited by 10
“Some diseases are caused by protein misfolding, while others are caused by residue mutation or modification 43,73 .”
Compact Luminol Chemiluminophores for In Vivo Detection and Imaging of β-Sheet Protein Aggregates
Wang, Q., Zhong, J., Li, K., Wu, J., Wang, X., Shen, J., Dai, J., & Cheng, Y. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c03776 · Cited by 9
Natural Compounds as Inhibitors of Aβ Peptide and Tau Aggregation
Monteiro, K. L. C., de Aquino, T. M., & da Silva‐Júnior, E. F. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273273539231114095300 · Cited by 12
A qualitative analysis of an A β -monomer model with inflammation processes for Alzheimer’s disease
Ciuperca, I. S., Pujo-Menjouet, L., Tine, L. M., Torres, N., & Volpert, V. A. (2024) · Royal Society Open Science · doi:10.1098/rsos.231536 · Cited by 15
“…the neurons. β However, if the concentration of A β -oligomers is high enough, then a reaction of stress called unfolded protein response (UPR) [4] is triggered which leads to a decrease of A -monomer production, while the rest of oligomers diffuse in the neuronal environment. β In this…”
Hennig, J., Andrésen, C., Museth, A. K., Lundström, P., Tibell, L. A. E., & Jonsson, B. (2014) · Biochemistry · doi:10.1021/bi500606j · Cited by 9
LED-based interferometric reflectance imaging sensor for the detection of amyloid-β aggregation
Cheng, X. R., Daaboul, G. G., Ünlü, M. S., & Kerman, K. (2013) · The Analyst · doi:10.1039/c3an01307c · Cited by 9
de Pedro‐Cuesta, J., Martínez‐Martín, P., Rábano, A., Alcalde-Cabero, E., López, F. J. G., Almazán‐Isla, J., Ruiz-Tovar, M., Medrano, M.-J., Avellanal, F., Calero, O., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150884 · Cited by 9
“logic toxic deposits of misfolded proteins [105–107]”
Ultrasensitive Measurement of Ca2+ Influx into Lipid Vesicles Induced by Protein Aggregates
Flagmeier, P., De, S., Wirthensohn, D. C., Lee, S. F., Vincke, C., Muyldermans, S., Knowles, T. P. J., Gandhi, S., Dobson, C. M., & Klenerman, D. (2017) · Angewandte Chemie · doi:10.1002/ange.201700966 · Cited by 9
Protein aggregation-inhibition: a therapeutic route from Parkinson’s disease to sickle cell anemia
Martins, G. F., & Galamba, N. (2023) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2023.2201406 · Cited by 9
“2002; Soto 2003) posits a relationship with protein misfolding and aggregation, resulting in the formation of abnormal protein aggregates, generally referred to as amyloids (Trojanowski and Lee 2003; Aguzzi and O’Connor 2010; Sweeney et al.”
BackgroundConformational states of HRPA1 induced by thermal unfolding: Effect of low molecular weight solutes
Carvalho, A. S., Santos, A. M., Neves‐Petersen, M. T., Petersen, S. B., Aires-Barros, M. R., & Melo, E. P. (2004) · Biopolymers · doi:10.1002/bip.20100 · Cited by 9
Peptide Amyloid Surface Display
Rubio, M. A., Schlamadinger, D. E., White, E. M., & Miranker, A. D. (2014) · Biochemistry · doi:10.1021/bi5011442 · Cited by 9
Transneuronal Degeneration of Thalamic Nuclei following Middle Cerebral Artery Occlusion in Rats
Chang, S., Cherng, J., Wang, D., Yu, S.-P., Liou, N.-H., & Hsu, M. (2016) · BioMed Research International · doi:10.1155/2016/3819052 · Cited by 9
Characterizing Structural Stability of Amyloid Motif Fibrils Mediated by Water Molecules
Choi, H., Chang, H. J., Lee, M., & Na, S. (2017) · ChemPhysChem · doi:10.1002/cphc.201601327 · Cited by 9
ER stress in neurodegenerative disease: from disease mechanisms to therapeutic interventions
Cabral‐Miranda, F., & Hetz, C. A. (2017) · Endoplasmic Reticulum Stress in Diseases · doi:10.1515/ersc-2017-0002 · Cited by 11
“Protein misfolding disorders (PMDs) include Alzheimer ́s disease (AD), Parkinson ́s disease (PD), amyotrophic lateral sclerosis (ALS), Huntington ́s disease (HD), prion-related disorders (PrDs), among others [15] and different PMDs are marked by distinct misfolded protein aggregates that arise in divergent brain regio…”
BackgroundHeat Shock Proteins and Protein Quality Control in Alzheimer’s Disease
van Leeuwen, F. W., & Kampinga, H. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00010-9 · Cited by 10
Identifying Disease Signatures in the Spinocerebellar Ataxia Type 1 Mouse Cortex
Luttik, K. P., Olmos, V. B., Owens, A., Khan, A., Yun, J., Driessen, T. M., & Lim, J. (2022) · Cells · doi:10.3390/cells11172632 · Cited by 9
Advances in our Understanding of Neurodegeneration
Jellinger, K. A. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50142-3 · Cited by 15
Joloudar, T. N., Saboury, A. A., Shasaltaneh, M. D., Bahramikia, S., Ebrahimi, M. A., & Ghasemi, A. (2017) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-017-1175-0 · Cited by 9
The Amyloid Phenomenon and Its Significance
Dobson, C. M. (2013) · Wiley eBooks · doi:10.1002/9783527654185.ch1 · Cited by 9
Syväoja, S. S., Raitamaa, L., Helakari, H., Kantola, J., Järvelä, M., Kananen, J., Isokoski, V., Korhonen, V. O., Väyrynen, T., Tuovinen, T., et al. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121290 · Cited by 8
“Moreover, given that the accumulation of protein inclusions are associated with various neurodegenerative diseases (Ross et al., 2004; Soto, 2003), the enhanced accuracy provided by combining phase and magnitude data to examine the driving forces behind brain waste clearance represents a promising…”
van Ewijk, C., Jain, G., Knelissen, Y. K., Maity, S., van der Wel, P. C. A., & Roos, W. H. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c05571 · Cited by 11
A generic approach to decipher the mechanistic pathway of heterogeneous protein aggregation kinetics
Tikader, B., Maji, S. K., & Kar, S. (2021) · Chemical Science · doi:10.1039/d1sc03190b · Cited by 8
Amyloids on Membrane Interfaces: Implications for Neurodegeneration
Mahakud, A. K., Shaikh, J., Iqbal, V. V. R., Gupta, A., Tiwari, A., & Saleem, M. (2022) · The Journal of Membrane Biology · doi:10.1007/s00232-022-00245-x · Cited by 8
“The term amyloid was initially used exclusively for amyloid plaques (extracellular protein deposits in Alzheimer’s disease), but currently, it refers to all kinds of misfolded protein aggregates leading to a variety of neurodegenerative disorders (Soto 2003).”
BackgroundLork, A. A., Rabasco, S., Ernst, C., du Toit, A., Rizzoli, S. O., & Phan, N. T. N. (2024) · Chemical Science · doi:10.1039/d3sc05629e · Cited by 9
Catalysis driven by an amyloid–substrate complex
Sawazaki, T., Sasaki, D., & Sohma, Y. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2314704121 · Cited by 8
Implications of liquid-liquid phase separation and ferroptosis in Alzheimer's disease
Wang, F., Chen, Z., Zhou, Q., Sun, Q., Zheng, N., Chen, Z., Lin, J., Li, B., & Li, L. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110083 · Cited by 9
Barrea, R. A., Antipova, O. A., Gore, D. B., Heurich, R., Vukonich, M., Kujala, N. G., Irving, T. C., & Orgel, J. P. R. O. (2014) · Journal of Synchrotron Radiation · doi:10.1107/s1600577514012259 · Cited by 8
“Protein misfolding reactions (amyloidosis) are the source of numerous human pathologies, including Alzheimer’s disease (Malinchik et al., 1998), Parkinson’s disease, amyotrophic lateral sclerosis, cystic fibrosis and polyglutamine diseases (Soto, 2003).”
BackgroundSharma, B., & Paul, S. (2016) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2016.10.086 · Cited by 8
Crook, Z. R., Sevilla, G. P., Mhyre, A. J., & Olson, J. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9853-1_21 · Cited by 8
A unifying model for the propagation of prion proteins in yeast brings insight into the [PSI+] prion
Lemarre, P., Suzanne, S. S., & Pujo-Menjouet, L. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007647 · Cited by 9
“Amyloids are self-perpetuating protein aggregates, involved in many neurodegenerative diseases in mammals such as Alzheimer’s Disease, Parkinsons’s Disease, Creutzfeldt-Jakob Disease, Huntington’s Disease [1].”
Metadata
- Authors
- Soto, C.
- Corresponding author
- Soto, Claudio
- ORCID
- Soto, Claudio
- Venue
- Nature Reviews Neuroscience
- Published
- 2003-01
- Volume
- 4
- Issue
- 1
- Pages
- 49-60
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2007157911
- Cited by
- 1,506
- References
- 154
- Citations by year
- 2026: 45 · 2025: 70 · 2024: 75 · 2023: 73 · 2022: 95 · 2021: 88 · 2020: 107 · 2019: 80 · 2018: 86 · 2017: 107 · 2016: 92 · 2015: 75 · 2014: 67 · 2013: 45 · 2012: 57
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- protein misfolding, neurodegenerative diseases, protein aggregation, protein accumulation, neuronal apoptosis, common pathogenic mechanisms, therapeutic target
- MeSH terms
- Animals, Brain, Brain Chemistry, Humans, Protein Folding, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.